In Q1 2025, the Company will discuss the plans for NDA submission under a potential accelerated approval path for bitopertin ...

Intensity Therapeutics, Inc. ("Intensity" or the "Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...

David Yurman founded his eponymous jewelry company alongside his wife Sybil. Just two years later the company would release a ...

OCALA, FL / ACCESSWIRE / January 9, 2025 / Today Nobility Homes, Inc. (OTCQX:NOBH) announced sales and earnings results for its fiscal year ended November 2, 2024. Sales for fiscal year 2024 were $51.